Con: Antifibrinolytics are not safe and effective in patients undergoing liver transplantation.
Ramsay
Michael A E
MA
Department of Anesthesiology and Pain Management, Baylor University Medical Center, Dallas, TX 75246, USA. docram@baylorhealth.edu
D000933:Antifibrinolytic Agents / Q000009:adverse effects*; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control; D005342:Fibrinolysis / Q000187:drug effects; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D019851:Thrombophilia / Q000139:chemically induced; D016896:Treatment Outcome
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D007611:Aprotinin